The Hidden Faces of Sarcoidosis: Atypical Presentations and Strategies to Prevent Misdiagnosis
Dr. Abdelwahab Arrazaghi, MD, FABIM, FRCPC, Specialist in Internal Medicine and Cardiovascular Diseases
Introduction
Sarcoidosis is a complex and enigmatic multisystem inflammatory disease of unknown etiology, typically characterized by the presence of non-caseating granulomas in affected tissues. While it most commonly involves the lungs and lymph nodes, sarcoidosis can affect virtually any organ system. Due to its varied and often nonspecific clinical presentations, sarcoidosis is frequently misdiagnosed or diagnosed late, which can lead to inappropriate treatments and adverse patient outcomes. This article explores the atypical presentations of sarcoidosis, focusing on manifestations that fall outside the classical pulmonary and mediastinal forms, aiming to increase awareness among clinicians to prevent diagnostic errors.
1. Cardiac Sarcoidosis
Cardiac involvement in sarcoidosis is potentially life-threatening but often goes undiagnosed because it can mimic other cardiac diseases. Autopsy studies suggest that up to 25% of sarcoidosis patients may have cardiac involvement, though clinical symptoms are observed in only 5% of cases.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
Advanced imaging techniques, including cardiac MRI and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), have proven beneficial in identifying myocardial inflammation and granulomatous lesions. Electrocardiograms (ECGs) and Holter monitors are also helpful in detecting arrhythmias early. A high index of suspicion is necessary for patients with unexplained arrhythmias or heart block, particularly in young patients without traditional risk factors.
2. Neurosarcoidosis
Neurosarcoidosis accounts for about 5-15% of sarcoidosis cases and presents a diagnostic challenge due to its wide range of neurologic manifestations.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
MRI with gadolinium contrast is the preferred imaging modality for neurosarcoidosis, as it helps detect leptomeningeal and parenchymal lesions. Cerebrospinal fluid (CSF) analysis often reveals lymphocytic pleocytosis and elevated protein levels. Biopsy remains the definitive diagnostic tool but is often challenging to obtain. Early diagnosis is crucial, as delayed treatment can lead to permanent neurological deficits.
3. Ocular Sarcoidosis
Ocular sarcoidosis may be the first or only sign of sarcoidosis in up to 30% of patients and can have severe implications for vision if not promptly diagnosed.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
A slit-lamp examination can reveal anterior uveitis, while fundus examination and imaging (such as OCT) can identify posterior uveitis and retinal granulomas. Ophthalmologists play a key role in recognizing ocular sarcoidosis, and patients presenting with uveitis or unexplained vision changes should be screened for systemic sarcoidosis.
4. Musculoskeletal Sarcoidosis
Musculoskeletal involvement in sarcoidosis is often under-recognized and can mimic rheumatologic conditions, particularly rheumatoid arthritis and systemic lupus erythematosus.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
Musculoskeletal symptoms, especially when accompanied by erythema nodosum, should raise suspicion for sarcoidosis. Radiographic imaging, including X-rays and MRI, may reveal characteristic bone lesions. Muscle biopsy can confirm granulomatous inflammation in cases of suspected sarcoid myopathy.
Recommended by LinkedIn
5. Cutaneous Sarcoidosis
Cutaneous manifestations are present in about 25% of sarcoidosis patients and may be the first sign of disease. These manifestations vary widely, and certain types can mimic other dermatologic conditions.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
Skin biopsy is essential to confirm granulomatous inflammation in cutaneous sarcoidosis. Dermatoscopy and histopathology can help differentiate it from other granulomatous skin diseases. Recognizing skin manifestations is crucial as they may be the initial indication of systemic sarcoidosis.
6. Hepatic and Splenic Sarcoidosis
While liver and spleen involvement in sarcoidosis is common, it is often asymptomatic and discovered incidentally on imaging studies.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
Ultrasound or CT scans can identify hepatosplenomegaly and focal lesions in the liver and spleen. Liver biopsy may reveal granulomas but is not always necessary unless liver function is severely impaired. Clinicians should consider sarcoidosis in patients with unexplained hepatosplenomegaly, particularly when associated with other systemic signs.
7. Renal Sarcoidosis
Renal involvement is an under-recognized manifestation of sarcoidosis that can lead to chronic kidney disease if not appropriately managed.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
Patients with unexplained hypercalcemia or renal insufficiency should be evaluated for sarcoidosis, especially if they have other systemic symptoms. Renal ultrasound or CT can detect nephrocalcinosis, while renal biopsy may confirm granulomatous interstitial nephritis.
8. Gastrointestinal Sarcoidosis
Gastrointestinal sarcoidosis is rare but can mimic other inflammatory or malignant conditions, particularly in the stomach.
Common Presentations:
Diagnosis and Prevention of Misdiagnosis:
Endoscopy with biopsy is crucial to differentiate gastrointestinal sarcoidosis from other inflammatory or neoplastic diseases. Histopathological confirmation of non-caseating granulomas in the gastrointestinal tract is often required.
Conclusion
The diverse and atypical presentations of sarcoidosis underscore the importance of a high index of suspicion in patients presenting with multisystemic symptoms, especially when initial diagnostics are inconclusive. Clinicians should adopt a systematic approach when evaluating potential sarcoidosis cases, incorporating advanced imaging, histopathological analysis, and a multidisciplinary perspective to reduce the risk of misdiagnosis. Early and accurate identification of atypical sarcoidosis can improve patient outcomes, prevent irreversible damage to vital organs, and reduce unnecessary interventions for misdiagnosed conditions.
References